A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Brandon Gee, 27, from London, has lost 8st—and is still shedding pounds—by combining Mounjaro jabs with an extreme walking habit of 30,000 steps a day. Once 25st and barely able to walk 15 minutes, ...

Mounjaro on the NHS: Expert advice on what you need to know Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility criteria ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

Rosie O'Donnell, who's been opening up about her weight-loss journey online, celebrated her progress in a new post.

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.